NasdaqGM:SIBNMedical Equipment
SI‑BONE (SIBN) Losses Narrow In Q4 And Test Bearish Narratives On Profit Path
SI-BONE (SIBN) has wrapped up FY 2025 with Q4 revenue of about US$56.4 million and a basic EPS loss of US$0.04, alongside a trailing twelve month revenue base of roughly US$200.9 million and a TTM EPS loss of US$0.44. Over the past six quarters, revenue has moved from US$40.3 million in Q3 2024 to US$56.4 million in Q4 2025. Over the same period, quarterly basic EPS has ranged from a loss of US$0.16 in Q3 2024 to a loss of US$0.04 in the latest quarter, presenting a picture of expanding scale...